Form 8-K - Current report:
SEC Accession No. 0001193125-20-143990
Filing Date
2020-05-15
Accepted
2020-05-15 16:16:10
Documents
12
Period of Report
2020-05-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d812938d8k.htm   iXBRL 8-K 63987
  Complete submission text file 0001193125-20-143990.txt   191761

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rgen-20200513.xsd EX-101.SCH 3082
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgen-20200513_lab.xml EX-101.LAB 18908
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgen-20200513_pre.xml EX-101.PRE 11871
11 EXTRACTED XBRL INSTANCE DOCUMENT d812938d8k_htm.xml XML 3513
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-14656 | Film No.: 20885435
SIC: 2836 Biological Products, (No Diagnostic Substances)